Login / Signup

Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).

Shiro TanakaSatoshi MoriHiroshi HaginoToshitsugu Sugimoto
Published in: Journal of bone and mineral metabolism (2020)
We reported the design and rationale for the JOINT-05. The trial is registered with the Japan Registry of Clinical Trials (jRCTs031180235) and the University Hospital Medical Information Network-Clinical Trials Registry (UMIN000015573).
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • bone mineral density
  • open label
  • randomized controlled trial
  • healthcare
  • double blind
  • postmenopausal women